. Author manuscript; available in PMC: 2012 May 9.

Published in final edited form as: Prostate. 2009 Mar 1;69(4):419–427. doi: 10.1002/pros.20908

TABLE III.

Frequencies of Risk Alleles in Case Subjects by Clinical Stage

				P-value with PSA in controls^a	Allele frequencies in cases			Test for difference T1candT2/T3/T4 P-value^c
Variable	Chr	Position^a	Reported risk allele	P-value with PSA in controls^a	All^b (N=2,893)	T1c (N=958)	T2/T3/T4 (N=1,731)	Test for difference T1candT2/T3/T4 P-value^c
rs721048	2p15	63,043,382	A	0.86	0.20	0.20	0.20	0.54
rs2660753	3p12	87,193,364	T	0.78	0.10	0.10	0.10	0.58
rs9364554	6q25	160,804,075	T	0.330	0.33	0.33	0.34	0.58
rs10486567	7p15	27,749,803	C	3.0E–04	0.78	0.79	0.77	0.049
rs6465657	7q21	97,654,263	C	0.45	0.51	0.51	0.51	0.60
rs16901979	8q24 (2)	128,194,098	A	0.09	0.06	0.05	0.06	0.28
rs6983267	8q24 (3)	128,482,487	G	0.10	0.56	0.55	0.57	0.15
rs1447295	8q24(1)	128,554,220	A	0.87	0.17	0.16	0.17	0.30
rs1571801	9q33	121,506,927	T	0.79	0.31	0.32	0.31	0.75
rs10993994	10q11	51,219,502	T	1.0E–03	0.43	0.44	0.42	0.19
rs4962416	10q26	126,686,862	G	6.0E–03	0.24	0.24	0.25	0.82
rs10896449	11q13	68,751,243	G	0.4	0.49	0.49	0.49	0.85
rs4430796	17q12	33,172,153	T	7.9E–05	0.61	0.61	0.61	0.78
rs1859962	17q24.3	66,620,348	G	0.23	0.54	0.54	0.55	0.76
rs2735839	19q13	56,056,435	G	0.05	0.88	0.89	0.88	0.71
rs5945619	Xp11	51,074,708	G	0.05	0.42	0.42	0.43	0.77

Build35.

A subset of cases (N=210) where clinical stage are T0, T1a, T1b, or could not be assessed.

P-values were based on allelic test assuming a multiplicative model.